{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:17:37Z","timestamp":1770988657167,"version":"3.50.1"},"reference-count":43,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Background: Post-stroke spasticity (PSS) is a common complication in stroke survivors, significantly impairing functional recovery and quality of life. Despite its prevalence, Italy lacks national guidelines or structured good clinical practice documents, resulting in heterogeneous clinical management. Methods: An Italian Delphi study was conducted to establish expert-based recommendations for PSS management. A panel of 93 rehabilitation medicine specialists and neurologists, each with over 5 years of experience in PSS management with botulinum toxin A (BoNT-A), participated in two rounds of voting on 47 statements drafted and approved by seven Key Opinion Leaders (KOLs), recognized for their national and international expertise. Consensus was defined as \u226575% of respondents answering \u2018strongly agree\u2019 or \u2018somewhat agree\u2019. Results: In Round 1, consensus was reached for 90% of statements; five items did not achieve the threshold. After revision and a second round, consensus was achieved for all items, including consideration of lesion site in clinical management and the role of adjuvant post-injection interventions. The panel\u2019s heterogeneity ensured broad representativeness. Conclusion: This Delphi study provides the first structured Italian expert recommendations for PSS management. Full consensus was reached in all 47 statements and in the Symptoms domain, particularly regarding pain, stiffness and heaviness, which highlights the importance of a structured framework to support consistent, individualized care. By standardizing patient assessment, treatment planning, and follow-up strategies, these findings provide a practical reference for clinicians.<\/jats:p>","DOI":"10.3390\/toxins18020094","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:28:11Z","timestamp":1770910091000},"page":"94","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Good Clinical Practices for the Management of Post-Stroke Spasticity with BoNT-A: A Delphi-Based Approach from the Italian Expert Group"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-6283","authenticated-orcid":false,"given":"Alessio","family":"Baricich","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"},{"name":"IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1043-7738","authenticated-orcid":false,"given":"Carmelo","family":"Chisari","sequence":"additional","affiliation":[{"name":"Unit of Neurorehabilitation, Department of Neuroscience, University Hospital of Pisa, 56124 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1317-7994","authenticated-orcid":false,"given":"Paolo","family":"De Blasiis","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Basilicata, 85100 Potenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Millevolte","sequence":"additional","affiliation":[{"name":"Neurorehabilitation Clinic, Marche University Hospital, 60126 Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3558-8276","authenticated-orcid":false,"given":"Alessandro","family":"Picelli","sequence":"additional","affiliation":[{"name":"Center for Research in Neuromotor and Cognitive Rehabilitation, Section of Physical Medicine and Rehabilitation, Department of Neuroscience, Biomedicine, and Movement, University of Verona, 37124 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-8485","authenticated-orcid":false,"given":"Andrea","family":"Santamato","sequence":"additional","affiliation":[{"name":"Neurorehabilitation and Spinal Cord Rehabilitation and Functional Recovery Section, Policlinico di Foggia, 71122 Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia Maria","family":"Caglioni","sequence":"additional","affiliation":[{"name":"Ipsen, 20124 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Molteni","sequence":"additional","affiliation":[{"name":"Villa Beretta Rehabilitation Center, Valduce Hospital, Costa Masnaga, 23845 Lecco, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1747-4949.2011.00594.x","article-title":"Epidemiology of stroke in Italy","volume":"6","author":"Sacco","year":"2011","journal-title":"Int. J. Stroke"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10072-012-1185-8","article-title":"Epidemiology of stroke in northern Italy: The Cerebrovascular Aosta Registry, 2004\u20132008","volume":"34","author":"Corso","year":"2013","journal-title":"Neurol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/17474930241308142","article-title":"World Stroke Organization: Global Stroke Fact Sheet 2025","volume":"20","author":"Feigin","year":"2025","journal-title":"Int. J. Stroke"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1191\/0269215502cr512oa","article-title":"Prevalence of spasticity post stroke","volume":"16","author":"Watkins","year":"2002","journal-title":"Clin. Rehabil."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e085484","DOI":"10.1136\/bmjopen-2024-085484","article-title":"Comprehensive observational and longitudinal study on the outbreak of stroke-related spasticity focusing on early-onset management with botulinum neurotoxin (COLOSSEO-BoNT): Protocol for a real-world prospective observational study on upper limb spasticity","volume":"14","author":"Marano","year":"2024","journal-title":"BMJ Open"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chen, B., Yang, T., Liao, Z., Sun, F., Mei, Z., and Zhang, W. (2025). Pathophysiology and management strategies for post-stroke spasticity: An update review. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26010406"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1000004","DOI":"10.2340\/20030711-1000004","article-title":"Improving the management of post-stroke spasticity: Time for action","volume":"1","author":"Christofi","year":"2018","journal-title":"J. Rehabil. Med. Clin. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1212\/WNL.0b013e3182764c86","article-title":"Poststroke spasticity: Sequelae and burden on stroke survivors and caregivers","volume":"80","author":"Zorowitz","year":"2013","journal-title":"Neurology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Baricich, A., Wein, T., Cinone, N., Bertoni, M., Picelli, A., Chisari, C., Molteni, F., and Santamato, A. (2021). BoNT-A for post-stroke spasticity: Guidance on unmet clinical needs from a Delphi panel approach. Toxins, 13.","DOI":"10.3390\/toxins13040236"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11795735211036576","DOI":"10.1177\/11795735211036576","article-title":"Early identification, intervention and management of post-stroke spasticity: Expert consensus recommendations","volume":"13","author":"Bavikatte","year":"2021","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/mus.23699","article-title":"Spasticity, weakness, force variability, and sustained spontaneous motor unit discharges of resting spastic-paretic biceps brachii muscles in chronic stroke","volume":"48","author":"Chang","year":"2013","journal-title":"Muscle Nerve"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Li, S., and Francisco, G.E. (2015). New insights into the pathophysiology of post-stroke spasticity. Front. Hum. Neurosci., 9.","DOI":"10.3389\/fnhum.2015.00192"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"g4737","DOI":"10.1136\/bmj.g4737","article-title":"The management of spasticity in adults","volume":"349","author":"Nair","year":"2014","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33425\/2641-4333.1007","article-title":"Post-stroke spasticity (PSS): Setting up a PSS clinic\u2014Experience and results","volume":"1","author":"Ricciardi","year":"2018","journal-title":"Neurol. Res. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.11138\/FNeur\/2017.32.2.089","article-title":"The Italian real-life post-stroke spasticity survey: Unmet needs in the management of spasticity with botulinum toxin type A","volume":"32","author":"Picelli","year":"2017","journal-title":"Funct. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2396987318771174","article-title":"Identifying unmet needs in long-term stroke care using in-depth assessment and the post-stroke checklist\u2014The Managing Aftercare for Stroke (MAS-I) study","volume":"3","author":"Hotter","year":"2018","journal-title":"Eur. Stroke J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sarzy\u0144ska-D\u0142ugosz, I. (2023). An optimal model of long-term post-stroke care. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1129516"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1080\/09638288.2016.1198432","article-title":"An international survey of patients living with spasticity","volume":"39","author":"Barnes","year":"2017","journal-title":"Disabil. Rehabil."},{"key":"ref_19","first-page":"525","article-title":"Management of stroke patients submitted to botulinum toxin type A therapy: A Delphi survey of an Italian expert panel of specialist injectors","volume":"50","author":"Franceschini","year":"2014","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"ref_20","first-page":"jrm00065","article-title":"Site and size of lesion predict post-stroke spasticity: A retrospective magnetic resonance imaging study","volume":"52","author":"Ri","year":"2020","journal-title":"J. Rehabil. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"162754","DOI":"10.1155\/2014\/162754","article-title":"Association between severe upper limb spasticity and brain lesion location in stroke patients","volume":"2014","author":"Picelli","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1545968315585357","article-title":"Lesion characteristics of individuals with upper limb spasticity after stroke","volume":"30","author":"Cheung","year":"2016","journal-title":"Neurorehabil. Neural Repair"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.physio.2019.01.004","article-title":"Predictors of upper limb spasticity after stroke: A systematic review and meta-analysis","volume":"105","author":"Kennedy","year":"2019","journal-title":"Physiotherapy"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Levy, J., Karam, P., Forestier, A., Loze, J.Y., and Bensmail, D. (2023). Botulinum toxin use in patients with post-stroke spasticity: A nationwide retrospective study from France. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1245228"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e014819","DOI":"10.1136\/bmjopen-2016-014819","article-title":"Secondary prevention and cognitive function after stroke: A study protocol for a 5-year follow-up of the ASPIRE-S cohort","volume":"7","author":"Rohde","year":"2017","journal-title":"BMJ Open"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Platz, T. (2021). Post-stroke spasticity. Clinical Pathways in Stroke Rehabilitation, Springer.","DOI":"10.1007\/978-3-030-58505-1"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rohde, D., Gaynor, E., Large, M., Mellon, L., Bennett, K., Williams, D.J., Brewer, L., Hall, P., Callaly, E., and Dolan, E. (2019). Cognitive impairment and medication adherence post-stroke: A five-year follow-up of the ASPIRE-S cohort. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223997"},{"key":"ref_28","first-page":"446","article-title":"Effectiveness of a family-based program for post-stroke patients and families: A cluster randomized controlled trial","volume":"10","author":"Deepradit","year":"2023","journal-title":"Int. J. Nurs. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Cecchella, E., Bragazzi, N.L., Cotellessa, F., Campanella, W., Puce, L., Marinelli, L., Curr\u00e0, A., Schenone, C., Mori, L., and Trompetto, C. (2025). Barriers to long-term adherence in botulinum toxin therapy for post-stroke spasticity: Insights and implications from a single-center study in North Italy. Toxins, 17.","DOI":"10.3390\/toxins17030102"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0040-1722641","article-title":"Poststroke pain","volume":"41","author":"Yang","year":"2021","journal-title":"Semin. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2340\/16501977-0474","article-title":"Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: A secondary analysis from a double-blind placebo-controlled randomized clinical trial","volume":"42","author":"Baguley","year":"2010","journal-title":"J. Rehabil. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Reebye, R., Jacinto, L.J., Balbert, A., Biering-S\u00f8rensen, B., Carda, S., Draulans, N., Molteni, F., O\u2019Dell, M.W., Picelli, A., and Santamato, A. (2024). Multimodal therapy and use of adjunctive therapies to BoNT-A in spasticity management: Defining terminology to help enhance spasticity treatment. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1432330"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2010.03125.x","article-title":"International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments\u2014Introduction","volume":"17","author":"Esquenazi","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.11138\/FNeur\/2018.33.1.037","article-title":"Management of spasticity with onabotulinumtoxinA: Practical guidance based on the Italian real-life post-stroke spasticity survey","volume":"33","author":"Sandrini","year":"2018","journal-title":"Funct. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"jrm00134","DOI":"10.2340\/16501977-2753","article-title":"A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus","volume":"53","author":"Francisco","year":"2021","journal-title":"J. Rehabil. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Dalkey, N.C. (1969). The Delphi Method: An Experimental Study of Group Opinion, RAND Corporation.","DOI":"10.1016\/S0016-3287(69)80025-X"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"(2025). The Lancet Neurology. Neurorehabilitation as a cornerstone of recovery. Lancet Neurol., 24, 713.","DOI":"10.1016\/S1474-4422(25)00277-7"},{"key":"ref_38","unstructured":"Linstone, H.A., and Turoff, M. (1975). The Delphi Method: Techniques and Applications, RAND Corporation. Available online: https:\/\/www.foresight.pl\/assets\/downloads\/publications\/Turoff_Linstone.pdf."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Murphy, M.K., Black, N.A., Lamping, D.L., McKee, C.M., Sanderson, C.F., Askham, J., and Marteau, T. (1998). Consensus development methods, and their use in clinical guideline development. Health Technol. Assess., 2.","DOI":"10.3310\/hta2030"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: How to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J. Methodol."},{"key":"ref_41","first-page":"11","article-title":"We agree, don\u2019t we? The Delphi method for health environments research","volume":"13","author":"Taylor","year":"2020","journal-title":"HERD Health Environ. Res. Des. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies","volume":"67","author":"Diamond","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"120484","DOI":"10.1016\/j.techfore.2020.120484","article-title":"Consensus in the Delphi method: What makes a decision change?","volume":"163","author":"Barrios","year":"2021","journal-title":"Technol. Forecast. Soc. Chang."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/2\/94\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:13:29Z","timestamp":1770984809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/2\/94"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["toxins18020094"],"URL":"https:\/\/doi.org\/10.3390\/toxins18020094","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]}}}